![Joël Richard](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Perfil
Joël Richard is currently a member of the Scientific & Medical Council at GlioCure SAS. He previously worked as the Managing Director at OctreoPharm Sciences GmbH, Development Director at Ipsen Dreux, and Senior Vice President-Pharma Development at Ipsen SA. He is also currently serving as the Chief Scientific Officer at MedinCell SA, a position he has held since 2022 and will continue until 2023.
Cargos activos de Joël Richard
| Empresas | Cargo | Inicio |
|---|---|---|
GlioCure SAS
 GlioCure SAS BiotechnologyHealth Technology Operates as a biopharmaceutical company specializing in the discovery and development of new drugs targeting glioma and pediatric brain tumors | Corporate Officer/Principal | - |
Antiguos cargos conocidos de Joël Richard.
| Empresas | Cargo | Fin |
|---|---|---|
| MEDINCELL S.A. | Director Técnico/Científico/I+D | 01/02/2023 |
| IPSEN | Corporate Officer/Principal | - |
Ipsen Dreux | Corporate Officer/Principal | - |
OctreoPharm Sciences GmbH
 OctreoPharm Sciences GmbH Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Director Ejecutivo | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
6
Relaciones de 1er grado
5
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
Ipsen SA
 Ipsen SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
OctreoPharm Sciences GmbH
OctreoPharm Sciences GmbH Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
MedinCell SA
 MedinCell SA Pharmaceuticals: MajorHealth Technology Provides therapeutic solutions | Health Technology |
GlioCure SAS
GlioCure SAS BiotechnologyHealth Technology Operates as a biopharmaceutical company specializing in the discovery and development of new drugs targeting glioma and pediatric brain tumors | Health Technology |
Ipsen Dreux |
- Bolsa de valores
- Insiders
- Joël Richard
